Market research
FUM.LSE Futura Medical plc
LSE GBP Healthcare
Latest close
Loading market data…
Test a moving-average rule with historical data.
Market facts
- Market cap
- 2M
- P/E ratio
- Not available
- Analyst target
- 30
- Dividend yield
- Not available
- Beta
- -0.0
Profile
Company facts
- Exchange
- LSE
- Currency
- GBP
- Sector
- Healthcare
- Industry
- Biotechnology
- ISIN
- GB0033278473
- Market cap
- 2M
- P/E ratio
- Not available
- Analyst target
- 30
- Dividend yield
- Not available
- Beta
- -0.0
About
About Futura Medical plc
Futura Medical plc research, develops, and commercializes pharmaceutical and healthcare products for sexual health. The company's lead product includes Eroxon, a topical treatment for erectile dysfunction. It also develops WSD4000 for the treatment of sexual dysfunction in women. The company operates in the United Kingdom, the European Union, the United States, and internationally. Futura Medical plc was incorporated in 2001 and is headquartered in Guildford, the United Kingdom.
Visit company websiteCommunity
Investor discussion
1 comment
Sign in to join the FUM.LSE discussion.
5 years, 5 months ago
Futura Medical plc is currently in a long term uptrend where the price is trading 46.6% above its 200 day moving average.
From a valuation standpoint, the stock is 840.3% more expensive than other stocks from the Healthcare sector with a price to sales ratio of 4189.4.
Based on the above factors, Futura Medical plc gets an overall score of 1/5.